Hans Van Houte Nurix Therapeutics, Inc. (NRIX) insider trading activity

NRIX Quotes by TradingView

Hans Van Houte is Chief Financial Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 33,724 shares of NRIX, which is worth approximately $743,614. The most recent transaction as insider was on Oct 30, 2022, when has been sold 2,886 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.7K
33.88% 3M change
60.96% 12M change
Total Value Held $743,614

Hans van Houte Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 30 2022
BUY
Exercise of conversion of derivative security
-
2,886 Added 3.68%
75,542 Common Stock
Aug 01 2022
SELL
Open market or private sale
$11,784 $15.67 p/Share
752 Reduced 1.02%
72,656 Common Stock
Jul 30 2022
BUY
Exercise of conversion of derivative security
-
2,886 Added 3.78%
73,408 Common Stock
May 31 2022
BUY
Exercise of conversion of derivative security
$57,400 $0.84 p/Share
68,333 Added 49.21%
70,522 Common Stock
May 02 2022
SELL
Open market or private sale
$8,190 $11.75 p/Share
697 Reduced 24.15%
2,189 Common Stock
Apr 30 2022
BUY
Exercise of conversion of derivative security
-
2,886 Added 50.0%
2,886 Common Stock
Feb 24 2021
SELL
Open market or private sale
$1,413,218 $39.9 p/Share
35,419 Reduced 100.0%
0 Common Stock
Feb 24 2021
BUY
Exercise of conversion of derivative security
$121,841 $3.44 p/Share
35,419 Added 50.0%
35,419 Common Stock
Feb 22 2021
SELL
Open market or private sale
$212,827 $39.93 p/Share
5,330 Reduced 100.0%
0 Common Stock
Feb 22 2021
BUY
Exercise of conversion of derivative security
$5,437 $1.02 p/Share
5,330 Added 50.0%
5,330 Common Stock
Feb 18 2021
SELL
Open market or private sale
$489,803 $36.06 p/Share
13,583 Reduced 100.0%
0 Common Stock
Feb 18 2021
BUY
Exercise of conversion of derivative security
$11,410 $0.84 p/Share
13,583 Added 50.0%
13,583 Common Stock
HvH

Hans Van Houte

Chief Financial Officer
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRIX